Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

Topiramate, primarily used for epilepsy and migraine prevention, is emerging as a cost-effective treatment for weight loss ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Everyone should be eating protein, but Dr. Sowa says it’s "very, very important" when you’re on a weight loss journey. “It’s ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight loss drug trial ... s own Wegovy and Ozempic, and Eli Lilly’s ...

From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis ... than those taking a placebo, ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...